1. Home
  2. ENZ vs PMN Comparison

ENZ vs PMN Comparison

Compare ENZ & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENZ
  • PMN
  • Stock Information
  • Founded
  • ENZ 1976
  • PMN 2004
  • Country
  • ENZ United States
  • PMN Canada
  • Employees
  • ENZ N/A
  • PMN N/A
  • Industry
  • ENZ Medical Specialities
  • PMN Pharmaceuticals and Biotechnology
  • Sector
  • ENZ Health Care
  • PMN Health Care
  • Exchange
  • ENZ Nasdaq
  • PMN Nasdaq
  • Market Cap
  • ENZ 34.2M
  • PMN 29.8M
  • IPO Year
  • ENZ N/A
  • PMN N/A
  • Fundamental
  • Price
  • ENZ $0.56
  • PMN $0.96
  • Analyst Decision
  • ENZ
  • PMN
  • Analyst Count
  • ENZ 0
  • PMN 0
  • Target Price
  • ENZ N/A
  • PMN N/A
  • AVG Volume (30 Days)
  • ENZ 125.9K
  • PMN 43.3K
  • Earning Date
  • ENZ 03-12-2025
  • PMN 03-31-2025
  • Dividend Yield
  • ENZ N/A
  • PMN N/A
  • EPS Growth
  • ENZ N/A
  • PMN N/A
  • EPS
  • ENZ N/A
  • PMN N/A
  • Revenue
  • ENZ $30,314,000.00
  • PMN N/A
  • Revenue This Year
  • ENZ N/A
  • PMN N/A
  • Revenue Next Year
  • ENZ N/A
  • PMN N/A
  • P/E Ratio
  • ENZ N/A
  • PMN N/A
  • Revenue Growth
  • ENZ N/A
  • PMN N/A
  • 52 Week Low
  • ENZ $0.54
  • PMN $0.87
  • 52 Week High
  • ENZ $1.40
  • PMN $2.61
  • Technical
  • Relative Strength Index (RSI)
  • ENZ 28.08
  • PMN 56.16
  • Support Level
  • ENZ $0.56
  • PMN $0.90
  • Resistance Level
  • ENZ $0.69
  • PMN $0.95
  • Average True Range (ATR)
  • ENZ 0.03
  • PMN 0.06
  • MACD
  • ENZ 0.00
  • PMN 0.01
  • Stochastic Oscillator
  • ENZ 11.54
  • PMN 67.79

About ENZ Enzo Biochem Inc. ($0.01 Par Value)

Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. The company has one reportable segment, Products, which focuses on labeling and detection technologies from DNA to whole cell analysis, including a comprehensive portfolio of thousands of high-quality products, including antibodies, genomic probes, assays, biochemicals, and proteins.

About PMN ProMIS Neurosciences Inc. (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine is based on the use of two complementary techniques. The company applies its thermodynamic, computational discovery platform-ProMIS and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

Share on Social Networks: